Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Omvoh™ (mirikizumab-mrkz) – New drug approval
October 26, 2023 -Eli Lilly announced the FDA approval of Omvoh (mirikizumab-mrkz), for the treatment of moderately to severely active ulcerative colitis (UC) in adults.
